SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/5F0C6D44FF1C55EC0EB1C4E47E609BD0E824DDC215C50F959C8730EBB286B092A61D3EB95DD62DAE36AD068E90D78EC1>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/5F0C6D44FF1C55EC0EB1C4E47E609BD0E824DDC215C50F959C8730EBB286B092A61D3EB95DD62DAE36AD068E90D78EC1
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5F0C6D44FF1C55EC0EB1C4E47E609BD0E824DDC215C50F959C8730EBB286B092A61D3EB95DD62DAE36AD068E90D78EC1
http://www.w3.org/2000/01/rdf-schema#comment
"IGFBP-5 induces its pro-fibrotic effects at least in part via DOK5. IGFBP-5 and DOK5 are both increased in systemic sclerosis fibroblasts and tissues and may thus be acting in concert to promote fibrosis."
xsd:string
http://purl.uniprot.org/uniprot/#_B072E0D8FA6502E9AA7D52F21A6D7000E04F3B3AA33BC47F84FB0172E75DE281915AD8E6F4E3D05AD7D2B48B29CB81A4
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/5F0C6D44FF1C55EC0EB1C4E47E609BD0E824DDC215C50F959C8730EBB286B092A61D3EB95DD62DAE36AD068E90D78EC1
http://purl.uniprot.org/uniprot/Q91ZM9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5F0C6D44FF1C55EC0EB1C4E47E609BD0E824DDC215C50F959C8730EBB286B092A61D3EB95DD62DAE36AD068E90D78EC1
http://purl.uniprot.org/uniprot/#_Q91ZM9-mappedCitation-24551065
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5F0C6D44FF1C55EC0EB1C4E47E609BD0E824DDC215C50F959C8730EBB286B092A61D3EB95DD62DAE36AD068E90D78EC1